Transgene Financials
| TRGNF Stock | USD 1.59 0.00 0.00% |
Transgene |
Transgene Stock Summary
Transgene competes with BlueScope Steel, United States, Acme United, Skechers USA, and United Guardian. Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. The company was incorporated in 1979 and is headquartered in Illkirch-Graffenstaden, France. Transgene operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 143 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 400, Boulevard Gonthier |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.transgene.fr |
| Phone | 33 3 88 27 91 00 |
| Currency | USD - US Dollar |
Transgene Key Financial Ratios
There are many critical financial ratios that Transgene's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Transgene SA reports annually and quarterly.| Return On Equity | -0.36 | |||
| Return On Asset | -0.16 | |||
| Number Of Employees | 143 | |||
| Beta | 0.79 | |||
| Z Score | -5.6 |
Transgene Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Transgene's current stock value. Our valuation model uses many indicators to compare Transgene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Transgene competition to find correlations between indicators driving Transgene's intrinsic value. More Info.Transgene SA is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Transgene's earnings, one of the primary drivers of an investment's value.Transgene SA Systematic Risk
Transgene's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Transgene volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Transgene SA correlated with the market. If Beta is less than 0 Transgene generally moves in the opposite direction as compared to the market. If Transgene Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Transgene SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Transgene is generally in the same direction as the market. If Beta > 1 Transgene moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Transgene Pink Sheet analysis
When running Transgene's price analysis, check to measure Transgene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transgene is operating at the current time. Most of Transgene's value examination focuses on studying past and present price action to predict the probability of Transgene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transgene's price. Additionally, you may evaluate how the addition of Transgene to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |